Home›People›Tasuku Kitada
Tasuku Kitada

Tasuku Kitada

President, Head of R&D, Co-founder, director at Strand Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Mar 17, 2026·Suggest an edit

About Tasuku Kitada

Tasuku Kitada is a president, head of R&D, co-founder, director at Strand Therapeutics.

Tasuku Kitada first appears on SEC filings in 2019.

Experience

This experience comes from Tasuku Kitada's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tasuku Kitada in the role, so the role may have started earlier or lasted longer.

Strand Therapeutics Inc. Current
President, Head of R&D, Co-founder, director
Co-founder, Board Director, President, and Head of R&D (2018 – Present)
2018 – Present · Boston, MA
Develops mRNA medicines for people with cancer and autoimmune diseases.
Candriam
Senior Biotechnology Analyst
2015 – 2018
MIT
Postdoctoral Associate
2012 – 2015
UCLA
Postdoctoral Scholar
2011 – 2012

Key Colleagues at Startups

The people Tasuku Kitada works with at each company, as listed on that company's latest Form D.

Strand Therapeutics Inc. · Form D, Mar 17, 2026
Jeb Keiper
Jeb Keiper
Independent Board Director
Ala Alenazi
Ala Alenazi
Investment and director
Pegah Ebrahimi
Pegah Ebrahimi
Co-founder & Managing Partner, FPV Ventures, director
Samta Kundu
Samta Kundu
Chief Operating Officer
Jory Bell
Jory Bell
Director
Jacob Becraft
Jacob Becraft
CEO, Co-Founder and director

Sources

  1. SECStrand Therapeutics Inc. Form D, filed Mar 17, 2026